BGMD Share Price

Open 0.09 Change Price %
High 0.09 1 Day 0.01 12.50
Low 0.09 1 Week 0.03 50.00
Close 0.09 1 Month -0.01 -10.00
Volume 410 1 Year -0.27 -75.00
52 Week High 0.36
52 Week Low 0.00
BGMD Important Levels
Resistance 2 0.09
Resistance 1 0.09
Pivot 0.09
Support 1 0.09
Support 2 0.09
NASDAQ USA Most Active Stocks
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
ASTI 0.00 0.00%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
MU 28.76 1.16%
MU 28.76 1.16%
MU 28.76 1.16%
More..
NASDAQ USA Top Gainers Stocks
AMCF 0.10 100.00%
LOCM 0.09 50.00%
IPXL 12.70 37.30%
WRES 0.09 28.57%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
RGLS 1.70 21.43%
SCON 1.54 19.38%
CPRX 2.01 18.24%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
LLEN 0.01 -50.00%
VALV 0.02 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
More..

BG Medicine, Inc. (NASDAQ: BGMD)

BGMD Technical Analysis 2
As on 27th Mar 2017 BGMD Share Price closed @ 0.09 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.15 & Buy for SHORT-TERM with Stoploss of 0.07 we also expect STOCK to react on Following IMPORTANT LEVELS.
BGMD Target for March
1st Target up-side 0.13
2nd Target up-side 0.16
3rd Target up-side 0.18
1st Target down-side 0.07
2nd Target down-side 0.04
3rd Target down-side 0.02
BGMD Other Details
Segment EQ
Market Capital 35047004.00
Sector Healthcare
Industry Medical Laboratories & Research
Offical website http://www.bg-medicine.com
BGMD Address
BGMD
880 Winter Street
Suite 210
Waltham, MA 02451
United States
Phone: 781-890-1199
Fax: 781-895-1119
BGMD Latest News
Interactive Technical Analysis Chart BG Medicine, Inc. ( BGMD NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on BG Medicine, Inc.
BGMD Business Profile
BG Medicine, Inc. (BG Medicine) is a life sciences company focused on the discovery, development and commercialization of cardiovascular diagnostics to addresses unmet medical needs. The Company focuses on blood-based tests. Its lead product candidate in development is CardioSCORE, which is a multi-analyte biomarker-based blood test for atherothrombotic cardiovascular disease, commonly known as vulnerable plaque. In March 2011, the Company entered into a supply agreement with Health Diagnostic Laboratory, Inc. (HDL), pursuant to which HDL agreed to purchase manual galectin-3 test kits from the Company and to offer galectin-3 testing services to physicians in the United States. This manual version of Its Galectin-3 test is being marketed in the United States through a number of regional and national laboratory testing facilities. In addition, it has partnered with four diagnostic instrument manufacturers, which are developing automated instrument versions of its galectin-3 test.